Immunogenicity of anti-rabies vaccines (ARVs) marketed in Sri Lanka: a comparative study.

Rathnadiwakara H, Cliquet F, Wasniewski M, Thibault JC, Schereffer JL, Thammitiyagodage M, Ijas M, Samaranayake D, Gunatilake M

Open source

DOI
10.7774/cevr.2026.15.e13
Published
2026 Apr
Container
Clinical and experimental vaccine research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7774/cevr.2026.15.e13,
  title = {Immunogenicity of anti-rabies vaccines (ARVs) marketed in Sri Lanka: a comparative study.},
  author = {Rathnadiwakara H and Cliquet F and Wasniewski M and Thibault JC and Schereffer JL and Thammitiyagodage M and Ijas M and Samaranayake D and Gunatilake M},
  year = {2026},
  journal = {Clinical and experimental vaccine research},
  doi = {10.7774/cevr.2026.15.e13},
  url = {https://doi.org/10.7774/cevr.2026.15.e13}
}

RIS

TY  - JOUR
TI  - Immunogenicity of anti-rabies vaccines (ARVs) marketed in Sri Lanka: a comparative study.
AU  - Rathnadiwakara H
AU  - Cliquet F
AU  - Wasniewski M
AU  - Thibault JC
AU  - Schereffer JL
AU  - Thammitiyagodage M
AU  - Ijas M
AU  - Samaranayake D
AU  - Gunatilake M
PY  - 2026
JO  - Clinical and experimental vaccine research
DO  - 10.7774/cevr.2026.15.e13
UR  - https://doi.org/10.7774/cevr.2026.15.e13
ER  - 

APA

H, R., F, C., M, W., JC, T., JL, S., M, T., M, I., D, S., & M, G. (2026). Immunogenicity of anti-rabies vaccines (ARVs) marketed in Sri Lanka: a comparative study.. Clinical and experimental vaccine research. https://doi.org/10.7774/cevr.2026.15.e13

Source records